Amedisys Announces New Director

  Amedisys Announces New Director

Business Wire

BATON ROUGE, La. -- March 8, 2013

Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and
hospice care companies, announced today that Ms. Linda J. Hall has joined the
Board. The Amedisys Board, assisted by a national executive search firm,
conducted an extensive search for a qualified director to enhance the existing
strength of our Board. As a result of that process, the Board identified and
unanimously appointed Ms. Hall to our Board. Ms. Hall is the
Entrepreneur-in-Residence at the Carlson School of Management at the
University of Minnesota, and she works as a private consultant with several
companies, including a number of companies in the healthcare industry. Her
healthcare consulting clients have included Mayo Clinic, Blue Cross/Blue
Shield of Minnesota, Xylo Technologies and Children’s HeartLink.

Ms. Hall has significant management experience in the healthcare industry,
including previously as the CEO of MinuteClinic (which was sold to CVS
Pharmacy in 2006), the CEO of Accurate Home Care (a home-healthcare company
serving chronically ill pediatric patients), and as an interim executive at
UnitedHealth Group, leading their corporate social responsibility initiative
for AARP. In addition, her past management experience outside of healthcare
includes serving as President of Ceridian Performance Partners and Vice
President of Honeywell’s Worldwide Consumer Business Group.

Ms. Hall has substantial public company board experience. She currently serves
on the board of directors of Investors Real Estate Trust, a diversified real
estate investment trust which includes healthcare investments, where she
serves on the compensation, nominating and governance and investment
committees. Previously, she served on the boards of Health Fitness
Corporation, from 2008 until its sale in 2010; August Technology, from 2002
until a merger in 2006; and MTS Systems Corporation, from 1995 to 2006,
retiring due to a 10-year term limit. At MTS, she served as the lead director,
the chair of the compensation committee and as a member of the audit
committee. She also served as Chair, Vice-Chair and as a member of the
Executive Committee of the Ninth District Federal Reserve Bank Board.

Ms. Hall earned a Ph.D. from the University of Minnesota in 1980 and an M.A.
from the University of Michigan in 1970.

William F. Borne, Amedisys’ Chairman and CEO, stated, “We are pleased that Ms.
Hall has joined the Amedisys board. She has a wealth of board and executive
experience, especially in the healthcare industry, and we look forward to
benefiting from her valuable insights as a director of our Company.”

Amedisys, Inc. is headquartered in Baton Rouge, La. Its common stock trades on
the NASDAQ Global Select Market under the symbol AMED.

About Amedisys:

Amedisys, Inc. (NASDAQ: AMED) is a leading health care at home company
delivering personalized home health and hospice care to more than 360,000
patients each year. Amedisys is focused on delivering the care that is best
for our patients, whether that is home-based recovery and rehabilitation after
an operation or injury, care focused on empowering them to manage a chronic
disease, palliative care for those with a terminal illness, or hospice care at
the end of life. The Company's state-of-the-art advanced chronic care
management programs and leading-edge technology enables it to deliver quality
care based upon the latest evidence-based best practices. Amedisys is a
recognized innovator, being one of the first in the industry to equip its
clinicians with point-of-care laptop technology and referring physicians with
an internet portal that enables real-time coordination of patient care
seamlessly. Amedisys also has the industry's first-ever nationwide Care
Transitions program, designed to reduce unnecessary hospital readmissions
through patient and caregiver health coaching and care coordination, which
starts in the hospital and continues throughout completion of the patient's
home health plan of care. For more information about the Company, please

This press release includes statements that may constitute "forward-looking"
statements, usually containing the words "believe," "estimate," "project,"
"expect," "anticipate" or similar expressions. Forward-looking statements
inherently involve risks and uncertainties that could cause actual results to
differ materially from the forward-looking statements. Many of the factors
that could cause or contribute to such differences are described in the
Company's periodic reports and registrations statements filed with the
Securities and Exchange Commission, and include, but are not limited to the
following: general economic and business conditions, changes in or failure to
comply with existing regulations or the inability to comply with new
government regulations on a timely basis, changes in Medicare and other
medical reimbursement levels, ability to complete acquisitions announced from
time to time, and any financing related thereto, the ability to meet debt
service requirements and to comply with covenants in debt agreements, adverse
changes in federal and state laws relating to the health care industry,
demographic changes, availability and terms of capital, ability to attract and
retain qualified personnel, ongoing development and success of new start-ups,
ability to successfully integrate newly acquired agencies, changes in
estimates and judgments associated with critical accounting policies, business
disruption due to natural disasters or acts of terrorism, and various other
matters, many of which are beyond management's control. By making these
forward-looking statements, the Company undertakes no obligation to update
these statements for revisions or changes after the date of this release.

Our company website address is We use our website as
a channel of distribution for important company information. Important
information, including press releases, analyst presentations and financial
information regarding the Company is routinely posted on and accessible on the
"Investor Relations" subpage of our website, which is accessible by clicking
on the tab labeled "Investors" on our website home page. We will also use our
website to expedite public access to time-critical information regarding the
Company in advance of or in lieu of distributing a press release or a filing
with the Securities and Exchange Commission ("SEC") disclosing the same
information. In addition, we make available on the Investor Relations subpage
of our website (under the link "SEC filings") free of charge our annual
reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form
8-K, ownership reports on Forms 3, 4 and 5 and any amendments to those reports
as soon as practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our Code of
Ethical Business Conduct and the charters for the Audit, Compensation and
Nominating and Governance Committees of our Board are also available on the
Investor Relations subpage of our website (under the link "Corporate


For Investors:
Amedisys, Inc.
Kevin B. LeBlanc, 225-299-3391
Director of Investor Relations
For Media:
Amedisys, Inc.
Jacqueline Chen Valencia, 225-299-3688
Senior Vice President Marketing & Communications
Press spacebar to pause and continue. Press esc to stop.